NCT05033028 (SOAR) is a Phase 3 clinical trial of Smartphone app in Opioid-use Disorder, sponsored by NYU Langone Health.

Who is sponsoring NCT05033028?

NCT05033028 is sponsored by NYU Langone Health.

What drugs are being tested in NCT05033028?

Interventions in NCT05033028: Smartphone app.

What condition does NCT05033028 study?

NCT05033028 studies Opioid-use Disorder.

Is NCT05033028 still recruiting?

NCT05033028 is currently recruiting now. Last updated 27 February 2026.

Last reviewed 2026-02-27 · How we verify

NCT05033028: SOAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Smartphones for Opiate Addiction Recovery

Recruiting now Phase 3 Last updated 27 February 2026

What this trial tests

Phase 3 trial testing Smartphone app in Opioid-use Disorder in 225 participants. Currently enrolling.

Timeline

1 November 2021

Primary endpoint
31 May 2027

31 May 2027

Quick facts

Lead sponsor	NYU Langone Health
Phase	Phase 3
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	treatment
Enrollment	225
Start date	1 November 2021
Primary completion	31 May 2027
Estimated completion	31 May 2027
Sites	2 locations across United States

Drugs / interventions tested

Smartphone app

Conditions studied

Opioid-use Disorder — all drugs for Opioid-use Disorder →

Sponsor

NYU Langone Health — full company profile →

Who can join

Adults 18 to 85, any sex, with Opioid-use Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Treatments for opioid addiction exist, but effectiveness is compromised when subjects use illicit opiates during treatment. Reuse rates during treatment can be high, and reducing illicit opiate use during treatment has thus recently become a major NIDA policy goal. The 5-minute battery indicates the numerical probability that a patient will reuse illicit opiates within the next 7-10 days.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Smartphone app

Trials testing the same drug.

NCT06909500 — A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users · NA · not yet recruiting
NCT05897242 — A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults · NA · completed
NCT04451499 — The Effect of Adding Smartphone-based Platform to the Bariatric Surgery Preparation Process · NA · completed
NCT03564015 — Smartphone App to Improve Functional Outcomes in Ankle Sprains · NA · terminated
NCT04162132 — Contingency Management Using Smartphone App in Patients With SUD · completed

Other recruiting trials for Opioid-use Disorder

Currently open trials in the same condition.

NCT04783558 — Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk · NA · active not recruiting
NCT05011266 — Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder · Phase 2, PHASE3 · recruiting
NCT05039554 — Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment · NA · recruiting
NCT04738825 — Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With Pr · NA · recruiting
NCT04365920 — Recovery Management Checkups for Opioid Use Disorder Experiment · Phase 3 · active not recruiting

Other NYU Langone Health trials

Trials by the same sponsor.

NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05033028 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 27 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05033028.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing